SHARIFFA GUNAWARDENE: Open Payments
NPI 1881083368 · WELLINGTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$300 in 14 payments from 5 companies in 2025. Trend: 2023 $361 · 2024 $391 · 2025 $300
Food & beverage: $300
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $130 |
| Novo Nordisk Inc | 3 | $59 |
| PFIZER INC. | 2 | $46 |
| Lilly USA, LLC | 2 | $45 |
| ABBVIE INC. | 1 | $20 |
Products named: FARXIGA, PAXLOVID, ZEPBOUND, JARDIANCE, QULIPTA, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
